Patient-Reported Outcome Information Collected from Lupus Patients Using a Mobile Application: Compliance and Validation.


Journal

ACR open rheumatology
ISSN: 2578-5745
Titre abrégé: ACR Open Rheumatol
Pays: United States
ID NLM: 101740025

Informations de publication

Date de publication:
Feb 2022
Historique:
revised: 04 10 2021
received: 19 05 2021
accepted: 10 10 2021
pubmed: 11 11 2021
medline: 11 11 2021
entrez: 10 11 2021
Statut: ppublish

Résumé

Patient-reported outcomes (PROs) can provide critical information concerning the impact of a disease on an individual. Mobile technology to collect PRO data in an electronic format (ePRO) allows for frequent assessment in the person's regular environment. The goal of this study was to assess the compliance with a phone application (app) and validate ePRO information in individuals with systemic lupus erythematosus (SLE). A smartphone app that collects ePRO data from various clinical instruments was developed. Information was collected by both an ePRO and a paper-administered instrument as part of a multicenter randomized interventional clinical trial of patients meeting American College of Rheumatology (ACR) criteria for the classification of SLE. To determine agreement between PRO information collected in the different formats, intraclass correlation coefficients (ICCs), paired Student's t tests, and Bland-Altman plots were evaluated. Compliance and Cronbach's alpha were also assessed as a measure of survey reliability. For the 62 subjects from diverse ancestral backgrounds, compliance with ePRO completion was high (more than 75%). Cronbach alpha values for PROs indicated moderate to high survey reliability. The vast majority (73.4%) of ICC values were indicative of good to excellent reliability between measurement methods. Bland-Altman plots verified method agreement, and 87% of pairwise t tests yielded an insignificant difference between information collected with the different administration methods. The excellent compliance and the high level of consistency between data collected by paper and that collected by electronic methods indicate that the app provides a reliable means of cataloging real-time changes in PROs in SLE patients.

Identifiants

pubmed: 34758103
doi: 10.1002/acr2.11370
pmc: PMC8843762
doi:

Types de publication

Journal Article

Langues

eng

Pagination

99-109

Subventions

Organisme : Horizen Therapeutics
Organisme : Lupus Research Alliance
Organisme : RILITE Foundation
Organisme : Verizon Philanthropic Partnership

Informations de copyright

© 2021 The Authors. ACR Open Rheumatology published by Wiley Periodicals LLC on behalf of American College of Rheumatology.

Références

Arthritis Rheum. 2008 Jan 15;59(1):136-43
pubmed: 18163398
Curr Rheumatol Rep. 2018 Mar 17;20(4):20
pubmed: 29550947
Lupus. 2020 Feb;29(2):144-156
pubmed: 31924145
Scand J Rheumatol. 2015;44(5):354-8
pubmed: 26114379
Lupus. 2013 Apr;22(5):422-30
pubmed: 23423250
Semin Arthritis Rheum. 2012 Aug;42(1):56-65
pubmed: 22480408
Lupus. 2018 Apr;27(5):728-737
pubmed: 29087259
Lupus Sci Med. 2018 Dec 11;5(1):e000297
pubmed: 30613420
Arthritis Res Ther. 2021 Apr 19;23(1):121
pubmed: 33874994
Arthritis Rheum. 2007 Dec 15;57(8):1348-57
pubmed: 18050225
Ann Intern Med. 2020 Jun 2;172(11):ITC81-ITC96
pubmed: 32479157
Arthritis Care Res (Hoboken). 2011 Nov;63 Suppl 11:S37-46
pubmed: 22588757
Arthritis Care Res (Hoboken). 2021 Jan;73(1):100-109
pubmed: 33026713
AIDS Patient Care STDS. 2017 Feb;31(2):43-48
pubmed: 28051875
Brain Behav. 2017 Jun 09;7(7):e00743
pubmed: 28729945
J Rheumatol. 1997 Aug;24(8):1608-14
pubmed: 9263159
Arthritis Care Res (Hoboken). 2019 Aug;71(8):1028-1035
pubmed: 30144293
Arthritis Care Res (Hoboken). 2021 Jan;73(1):110-119
pubmed: 32741118
Fam Med. 2004 Sep;36(8):588-94
pubmed: 15343421
Trials. 2019 Mar 22;20(1):182
pubmed: 30902094
Health Qual Life Outcomes. 2015 Oct 07;13:167
pubmed: 26446159
Lupus Sci Med. 2016 Aug 24;3(1):e000144
pubmed: 27651918
Arthritis Res Ther. 2017 Oct 24;19(1):238
pubmed: 29065901
Best Pract Res Clin Rheumatol. 2013 Jun;27(3):363-75
pubmed: 24238693
Arthritis Care Res (Hoboken). 2017 Sep;69(9):1312-1321
pubmed: 28029753
PLoS One. 2020 Nov 2;15(11):e0241480
pubmed: 33137123
Biochem Med (Zagreb). 2015 Jun 05;25(2):141-51
pubmed: 26110027
Arthritis Res Ther. 2019 Dec 2;21(1):263
pubmed: 31791386
Lupus Sci Med. 2019 Dec 30;6(1):e000365
pubmed: 31921432
Lupus. 1999;8(8):660-70
pubmed: 10568904
Value Health. 2011 Mar-Apr;14(2):316-21
pubmed: 21402299

Auteurs

Kristy Bell (K)

AMPEL BioSolutions LLC, Charlottesville, Virginia.

Claire Dykas (C)

AMPEL BioSolutions LLC, Charlottesville, Virginia.

Bridget Muckian (B)

AMPEL BioSolutions LLC, Charlottesville, Virginia.

Brooke Williams (B)

AMPEL BioSolutions LLC, Charlottesville, Virginia.

Hope Rainey (H)

AMPEL BioSolutions LLC, Charlottesville, Virginia.

Maggy Comberg (M)

AMPEL BioSolutions LLC, Charlottesville, Virginia.

Mary Mora (M)

AMPEL BioSolutions LLC, Charlottesville, Virginia.

Katherine A Owen (KA)

AMPEL BioSolutions LLC, Charlottesville, Virginia.

Peter E Lipsky (PE)

AMPEL BioSolutions LLC, Charlottesville, Virginia.

Classifications MeSH